DALLAS, March 5, 2020 /PRNewswire/ -- Consumers expect the same level of digital capability and self enablement from their healthcare providers that they have become accustomed to in other industries; and, at the core of that expectation is the healthcare consumer's desire for the convenience of anytime, anywhere mobile access to their personal health information and pro

LAUSANNE, Switzerland, March 5, 2020 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the advancement

CHICAGO, March 5, 2020 /PRNewswire/ -- ImmersiveTouch has announced a collaboration with HP that strives to unleash the power of personalized medicine by providing the missing link between medical imaging and real-time surgery. This collaboration will pair ImmersiveTouch clinical software with HP hardware to create better healthcare outcomes at reduced costs. The compani

VANCOUVER, March 5, 2020 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its results for the quarter and year ended December 31, 2019, on Wednesday, March 11, 2020 after market close. The Company's executive management will discuss the resul

SOUTH SAN FRANCISCO, Calif., March 5, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced the presentation of new data demonstrating that using Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo] to treat patients with intracranial hemorrhage (ICH) associated with the oral Factor Xa inhibitors

GREENVILLE, N.C., March 5, 2020 /PRNewswire/ -- Eastern Nephrology Associates (ENA) has announced its participation and investment in a new entity aimed at improving healthcare outcomes for Americans living with kidney disease. This new population health management company,

BOSTON, March 5, 2020 /PRNewswire/ -- COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, today announced its board of directors has appointed C.K. Wang, M.D. as the company's chief medical officer (CMO). Since joining COTA in 2018, Dr. Wang has demonstrated his dedication to advancing COTA's mission of improving c

NEW YORK, March 5, 2020 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the company has appointed Yadin Shemmer and Adam K. Stern to serve as board me

TEL AVIV, Israel, March 5, 2020 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral, SCD1 modulator, currently in Phase 3 clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis announced today tha

SAN DIEGO, March 5, 2020 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, today announced that on March 4, 2020 it entered in